首页> 外文OA文献 >Efficacy and Safety of Glimepiride with or without Linagliptin Treatment in Patients with HNF1A-diabetes (Maturity Onset Diabetes of the Young Type 3): A Randomized, Double-blinded, Placebo-controlled, Crossover Trial (GLIMLINA)

【2h】

Efficacy and Safety of Glimepiride with or without Linagliptin Treatment in Patients with HNF1A-diabetes (Maturity Onset Diabetes of the Young Type 3): A Randomized, Double-blinded, Placebo-controlled, Crossover Trial (GLIMLINA)

机译：HNF1A-糖尿病患者（年轻型3型成熟型糖尿病患者中有或没有LinaglitiN治疗的疗效和安全性）：随机，双盲，安慰剂控制，交叉试验（Glimlina）

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Alexander S. Christensen; Sofie Hædersdal; Julie Støy; Heidi Storgaard; Ulla Kampmann; Julie L. Forman; Marta Seghieri; Jens J. Holst; Torben Hansen; Filip K. Knop; Tina Vilsbøll;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Efficacy and Safety of Glimepiride With or Without Linagliptin Treatment in Patients With HNF1A Diabetes (Maturity-Onset Diabetes of the Young Type 3): A Randomized, Double-Blinded, Placebo-Controlled, Crossover Trial (GLIMLINA) [J] . Christensen Alexander S., Haedersdal Sofie, Stoy Julie, Diabetes care . 2020,第9期

机译：HNF1A糖尿病患者（年轻型成熟糖尿病的患者中有或没有Linagliptin治疗的疗效和安全性）：随机，双盲，安慰剂控制，交叉试验（Glimlina）
2. Linagliptin as add-on to empagliflozin in a fixed-dose combination in Japanese patients with type 2 diabetes: Glycaemic efficacy and safety profile in a two-part, randomized, placebo-controlled trial [J] . Kaku Kohei, Haneda Masakazu, Tanaka Yuko, Diabetes, obesity & metabolism . 2019,第1期

机译：Linagliptin作为Empagliflozin在日本患者2型糖尿病患者的固定剂量组合中：血糖疗效和安全性曲线在两部分，随机，安慰剂对照试验中
3. Efficacy and safety of linagliptin plus insulin in Chinese patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial [J] . Yang Wenying, Shen Jie, Ye Binqi, Diabetes/metabolism research and reviews . 2019,第S1期

机译：Linagliptin Plus胰岛素在2型糖尿病患者中的疗效和安全性：随机，双盲，安慰剂对照试验
4. The Control Strength of Glucokinase in hepatocytes: A Predictor of Metabolic Defects in Maturity Onset Diabetes of the Young, Type 2 [C] . Loranne Agius, Susan Aiston, Christopher B. Newgard NATO advanced research workshop on technological and medical implications of metabolic control analysis . 2000

机译：肝细胞葡萄糖氨基酶的控制强度：年轻型成熟糖尿病代谢缺陷的预测因子，2型
5. Efficacy of the Chinese herbal formula CUF2 in the treatment of childhood asthma: Animal experiment, in vitro study and randomized, double-blinded, placebo-controlled clinical trial. [D] . Wong, Yeuk Oi. 2006

机译：中药配方CUF2在治疗儿童哮喘中的功效：动物实验，体外研究以及随机，双盲，安慰剂对照的临床试验。
6. Efficacy and Safety of Glimepiride With or Without Linagliptin Treatment in Patients With HNF1A Diabetes (Maturity-Onset Diabetes of the Young Type 3): A Randomized Double-Blinded Placebo-Controlled Crossover Trial (GLIMLINA) [O] . Alexander S. Christensen, Sofie Hædersdal, Julie Støy, 2020

机译：HNF1A糖尿病患者（年轻型成熟糖尿病的患者中有或没有Linagliptin治疗的疗效和安全性）：随机双盲安慰剂控制交叉试验（Glimlina）
7. Efficacy and Safety of Glimepiride with or without Linagliptin Treatment in Patients with HNF1A-diabetes (Maturity Onset Diabetes of the Young Type 3): A Randomized, Double-blinded, Placebo-controlled, Crossover Trial (GLIMLINA) [O] . Alexander S. Christensen, Sofie Hædersdal, Julie Støy, 2020

机译：HNF1A-糖尿病患者（年轻型3型成熟型糖尿病患者中有或没有LinaglitiN治疗的疗效和安全性）：随机，双盲，安慰剂控制，交叉试验（Glimlina）

Efficacy and Safety of Glimepiride with or without Linagliptin Treatment in Patients with HNF1A-diabetes (Maturity Onset Diabetes of the Young Type 3): A Randomized, Double-blinded, Placebo-controlled, Crossover Trial (GLIMLINA)

著录项

引文网络

相似文献

相关主题

期刊订阅